,

Peiyi Zhao1, Jiahao Wang1, Huiying Huang1

  • 1National Engineering Research Center of Ophthalmology and Optometry, Department of Biomaterials, School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.

PubMed
概括

一种新型的双药外体纳米载体通过抑制RPE细胞的增殖,迁移和EMT,有效地治疗增殖性玻璃红蛋白病变 (PVR). 这种有针对性的方法为与PVR相关的视力损失提供了一个有希望的治疗策略.